P100017S013

None

FDA Premarket Approval P100017 S013

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP100017S013
Classification NameNone
Applicant
PMAP100017
SupplementS013

Supplemental Filings

Supplement NumberDateSupplement Type
P100017Original Filing
S024 2021-02-05 30-day Notice
S023 2020-11-16 30-day Notice
S022 2019-04-10 30-day Notice
S021 2018-05-25 30-day Notice
S020 2017-06-27 135 Review Track For 30-day Notice
S019 2016-12-01 30-day Notice
S018 2016-06-01 30-day Notice
S017 2016-04-20 30-day Notice
S016 2016-03-28 30-day Notice
S015 2016-03-25 30-day Notice
S014 2015-07-29 Real-time Process
S013
S012 2015-03-26 30-day Notice
S011 2014-11-10 30-day Notice
S010 2014-10-24 30-day Notice
S009 2013-11-12 30-day Notice
S008 2013-10-21 30-day Notice
S007 2013-07-23 30-day Notice
S006 2013-05-01 30-day Notice
S005 2013-03-01 Normal 180 Day Track
S004 2013-02-04 30-day Notice
S003 2012-10-04 30-day Notice
S002 2012-04-02 135 Review Track For 30-day Notice
S001 2011-07-01 135 Review Track For 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00884999042681 P100017 014

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.